Sphera Funds Management Ltd. Ayala Pharmaceuticals, Inc. Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.99 - $4.15 $247,500 - $1.04 Million
-250,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$8.32 - $12.45 $2.08 Million - $3.11 Million
250,000 New
250,000 $2.13 Million

Others Institutions Holding AYLA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Ayala Pharmaceuticals, Inc.

AYLA Quotes by TradingView
  • Ticker AYLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,833,300
  • Description
  • Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...
More about AYLA
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email